Literature DB >> 22381555

Safe injection practices for administration of propofol.

Cecil A King1, Mary Ogg.   

Abstract

Sepsis and postoperative infection can occur as a result of unsafe practices in the administration of propofol and other injectable medications. Investigations of infection outbreaks have revealed the causes to be related to bacterial growth in or contamination of propofol and unsafe medication practices, including reuse of syringes on multiple patients, use of single-use medication vials for multiple patients, and failure to practice aseptic technique and adhere to infection control practices. Surveys conducted by AORN and other researchers have provided additional information on perioperative practices related to injectable medications. In 2009, the US Food and Drug Administration and the Centers for Disease Control and Prevention convened a group of clinicians to gain a better understanding of the issues related to infection outbreaks and injectable medications. The meeting participants proposed collecting data to persuade clinicians to adopt new practices, developing guiding principles for propofol use, and describing propofol-specific, site-specific, and practitioner-specific injection techniques. AORN provides resources to help perioperative nurses reduce the incidence of postoperative infection related to medication administration. Copyright Â
© 2012 AORN, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381555     DOI: 10.1016/j.aorn.2011.06.009

Source DB:  PubMed          Journal:  AORN J        ISSN: 0001-2092            Impact factor:   0.676


  3 in total

1.  Outbreak of bacterial endocarditis associated with an oral surgery practice: New Jersey public health surveillance, 2013 to 2014.

Authors:  Kathleen M Ross; Jason S Mehr; Rebecca D Greeley; Lindsay A Montoya; Prathit A Kulkarni; Sonya Frontin; Trevor J Weigle; Helen Giles; Barbara E Montana
Journal:  J Am Dent Assoc       Date:  2018-02-02       Impact factor: 3.634

2.  Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989-2014(1).

Authors:  Andrés Zorrilla-Vaca; Jimmy J Arevalo; Kevin Escandón-Vargas; Daniel Soltanifar; Marek A Mirski
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

3.  Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital.

Authors:  Shadi Baniasadi; Atosa Dorudinia; Mandana Mobarhan; Masoumeh Karimi Gamishan; Fanak Fahimi
Journal:  Braz J Infect Dis       Date:  2013-01-05       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.